Cover Image
Market Research Report

Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product, Disease, Application, and Country

Published by The Insight Partners Product code 819790
Published Content info 155 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product, Disease, Application, and Country
Published: February 27, 2019 Content info: 155 Pages
Description

The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025. The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of awareness about human microbiome science is likely to have a negative impact on the growth of the market in the coming years.

Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health. The Gut Health Congress was held in Hong Kong Asia in 2018, the conference explore in detail of diet & personalised nutrition, gastrointestinal microbiome and several case studies with regards to clinical studies, diagnostics studies, treatment methods, biomarker developments, molecular therapy and gastrointestinal diseases. Also, the 5th Microbiome R&D and Business Collaboration Congress was held in Taiwan, Asia in March 2019, the conference focused on recent developments in gut microbiome, skin microbiome, infant, women and oral health, therapeutics, microbiome and diet.

Also, many companies are designing and developing many microbiome therapies. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.

Japan is anticipated to lead the adoptions of Human microbiome across the Asia Pacific region through the forecast period. Researchers from Japan are using the outcomes of studies on centenarians in the country to try and produce new products that will replicate the beneficial aspects of their microbiota. The goal of the collaboration is to solve few of the major technological hurdles in advancing stem cell research. Moreover, Cykinso (Tokyo) received the US$ 2.3 million (270 million yen) funds from the Regional Health Care Industry Support Fund, develop and sell Mykinso or a test kit for intestinal flora. The company plans to use the funds for business development purposes, which include using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. Thus, the investments and the initiatives taken by the government are likely to propel the growth of the market in the forecast period.

Exhibit: Rest Of Asia Pacific Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION

  • By Product
  • Probiotics
  • Foods
  • Prebiotics
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION

  • By Disease
  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Others

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION

  • By Application
  • Therapeutics
  • Diagnostics
  • By Country
  • U.S.
  • Canada
  • Mexico
  • Companies Mentioned
  • Enterome
  • MicroBiome Therapeutics, LLC
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Osel Inc.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DuPont
  • BiomX Ltd.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents
Product Code: TIPRE00003317

TABLE OF CONTENTS

PART 1. INTRODUCTION

  • 1.1 SCOPE OF THE STUDY
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. ASIA PACIFIC HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. ASIA PACIFIC HUMAN MICROBIOME MARKET - MARKET LANDSCAPE

  • 3.1 OVERVIEW
  • 3.2 MARKET SEGMENTATION
    • 3.2.1 Asia Pacific Human Microbiome Market - By Product
    • 3.2.2 Asia Pacific Human Microbiome Market - By Disease
    • 3.2.3 Asia Pacific Human Microbiome Market - By Application
    • 3.2.4 Asia Pacific Human Microbiome Market North America
  • 3.3 PEST ANALYSIS
    • 3.3.1 Asia Pacific- PEST Analysis

PART 4. ASIA PACIFIC HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS

  • 4.1 KEY MARKET DRIVERS
    • 4.1.1 Rising Chronic Disease due to change in lifestyle
    • 4.1.2 Growing interest in Human Microbiome Treatment approach
  • 4.2 KEY MARKET RESTRAINTS
    • 4.2.1 Stringent regulatory environment
    • 4.2.2 Lack of Awareness About Human Microbiome Science
  • 4.3 KEY MARKET OPPORTUNITIES
    • 4.3.1 Growing Initiatives To Raise The Awareness in Emerging Nations
  • 4.4 FUTURE TRENDS
    • 4.4.1 The Human Microbiome Drug Development Is Revolutionizing The Medical Industry
  • 4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - ASIA PACIFIC ANALYSIS

  • 5.1 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS
  • 5.2 MARKET POSITIONING
  • 5.3 PERFORMANCE OF KEY PLAYERS

Enterome

Yakult Honsha Co., Ltd.

  • 5.4 EXPERT OPINIONS

PART 6. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
  • 6.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • 6.4 FOODS MARKET
    • 6.4.1 Overview
    • 6.4.2 Asia Pacific Foods Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.5 MEDICAL FOOD MARKET
    • 6.5.1 Overview
    • 6.5.2 Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.6 PROBIOTICS MARKET
    • 6.6.1 Overview
    • 6.6.2 Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.7 PREBIOTICS MARKET
    • 6.7.1 Overview
    • 6.7.2 Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.8 DRUGS MARKET
    • 6.8.1 Overview
    • 6.8.2 Asia Pacific Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.9 DIAGNOSTIC DEVICES MARKET
    • 6.9.1 Overview
    • 6.9.2 Asia Pacific Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
  • 6.10 SUPPLEMENTS MARKET
    • 6.10.1 Overview
    • 6.10.2 Asia Pacific Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE

  • 7.1 OVERVIEW
  • 7.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)
  • 7.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • 7.4 DIABETES MARKET
    • 7.4.1 Overview
    • 7.4.2 Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.5 CANCER MARKET
    • 7.5.1 Overview
    • 7.5.2 Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.6 AUTOIMMUNE DISORDERS MARKET
    • 7.6.1 Overview
    • 7.6.2 Asia Pacific Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.7 OBESITY MARKET
    • 7.7.1 Overview
    • 7.7.2 Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.8 MENTAL DISORDERS MARKET
    • 7.8.1 Overview
    • 7.8.2 Asia Pacific Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
  • 7.9 OTHERS MARKET
    • 7.9.1 Overview
    • 7.9.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

  • 8.1 OVERVIEW
  • 8.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)
  • 8.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • 8.4 DIAGNOSTICS MARKET
    • 8.4.1 Overview
    • 8.4.2 Asia Pacific Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
  • 8.5 THERAPEUTICS MARKET
    • 8.5.1 Overview
    • 8.5.2 Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025

  • 9.1 OVERVIEW
  • 9.2 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • 9.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • 9.4 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • 9.5 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • 9.6 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • 9.7 CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
    • 9.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
    • 9.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.8 JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
    • 9.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
    • 9.8.4 Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
  • 9.9 INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
    • 9.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
    • 9.9.2 India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
    • 9.9.3 India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
    • 9.9.4 India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
  • 10.3 ORGANIC GROWTH STRATEGIES
    • 10.3.1 Overview
    • 10.3.2 Product Launch & Approvals
    • 10.3.3 Expansion
    • 10.3.4 Patent and license
  • 10.4 INORGANIC GROWTH STRATEGIES
    • 10.4.1 Overview
    • 10.4.2 Acquisitions
    • 10.4.3 Partnerships, Collaborations & Agreements
    • 10.4.4 Joint Ventures

PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES

  • 11.1 ENTEROME
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 MICROBIOME THERAPEUTICS, LLC
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Information
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 REBIOTIX INC.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 YAKULT HONSHA CO., LTD.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 OSEL INC.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 Swot Analysis
    • 11.5.6 Key Developments
  • 11.6 VEDANTA BIOSCIENCES, INC.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Information
    • 11.6.4 Product Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 METABIOMICS CORPORATE
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 SYNTHETIC BIOLOGICS, INC.
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Information
    • 11.8.4 Product Portfolio
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 DUPONT
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 BIOMX
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Information
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

PART 12. APPENDIX

  • 12.1 ABOUT THE INSIGHT PARTNERS
  • 12.2 GLOSSARY OF TERMS
  • 12.3 METHODOLOGY
    • 12.3.1 Coverage
    • 12.3.2 Secondary Research
    • 12.3.3 Primary Research

LIST OF TABLES

  • TABLE 1. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 7. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 8. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 9. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 10. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 11. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 12. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 13. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
  • TABLE 14. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
  • TABLE 15. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
  • TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET
  • TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET
  • TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
  • TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET
  • TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET
  • TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
  • TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

  • FIGURE 1. JAPAN HUMAN MICROBIOME MARKET, REVENUE (US$ MN), 2018 & 2025
  • FIGURE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017
  • FIGURE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017
  • FIGURE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017
  • FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION
  • FIGURE 6. ASIA PACIFIC PEST ANALYSIS
  • FIGURE 7. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
  • FIGURE 8. ASIA PACIFIC HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025
  • FIGURE 9. ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
  • FIGURE 10. ASIA PACIFIC FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 11. ASIA PACIFIC MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 12. ASIA PACIFIC PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 13. ASIA PACIFIC PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 14. ASIA PACIFIC DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 15. ASIA PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 16. ASIA PACIFIC SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 17. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)
  • FIGURE 18. ASIA PACIFIC DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 19. ASIA PACIFIC CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 20. ASIA PACIFIC AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 21. ASIA PACIFIC OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 22. ASIA PACIFIC MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 23. ASIA PACIFIC OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 24. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)
  • FIGURE 25. ASIA PACIFIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 26. ASIA PACIFIC THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 27. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
  • FIGURE 28. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 29. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
  • FIGURE 30. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 31. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 32. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
  • FIGURE 33. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
  • FIGURE 34. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
  • FIGURE 35. INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
Back to Top